Kamilla Abdullayev

Kamilla Abdullayev

Auto-generated profile, based on publicly available information

Kamilla Abdullayev

Research Department of Clinical, Educational and Health Psychology, University College London

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
KAKamilla Abdullayev
Kamilla Abdullayev
OGOlivia Gorvett
Olivia Gorvett
ASAnna Sochiera
Anna Sochiera
LLLynn Laidlaw
Lynn Laidlaw
TCTimothy Chico
Timothy Chico
FMFaith Matcham
Faith Matcham
Objective The aim of this study is to understand stakeholder experiences of diagnosis of cardiovascular disease (CVD) to support the development of technological solutions that meet current needs. Specifically, we aimed to identify challenges in the process of diagnosing CVD, to identify discrepancies between patient and clinician experiences of CVD diagnosis, and to identify the requirements of future health technology solutions intended to improve CVD diagnosis. Design Semistructured focus groups and one-to-one interviews to generate qualitative data that were subjected to thematic analysis. Participants UK-based individuals (N=32) with lived experience of diagnosis of CVD (n=23) and clinicians with experience in diagnosing CVD (n=9). Results We identified four key themes related to delayed or inaccurate diagnosis of CVD: symptom interpretation, patient characteristics, patient–clinician interactions and systemic challenges. Subthemes from each are discussed in depth. Challenges related to time and communication were greatest for both stakeholder groups; however, there were differences in other areas, for example, patient experiences highlighted difficulties with the psychological aspects of diagnosis and interpreting ambiguous symptoms, while clinicians emphasised the role of individual patient differences and the lack of rapport in contributing to delays or inaccurate diagnosis. Conclusions Our findings highlight key considerations when developing digital technologies that seek to improve the efficiency and accuracy of diagnosis of CVD.

27 June 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
KAKamilla Abdullayev
Kamilla Abdullayev
TCTimothy Ja Chico
Timothy Ja Chico
MMMatthew Manktelow
Matthew Manktelow
OBOliver Buckley
Oliver Buckley
JCJoan Condell
Joan Condell
FMFaith Matcham
Faith Matcham
Introduction Cardiovascular diseases are highly prevalent among the UK population, and the quality of care is being reduced due to accessibility and resource issues. Increased implementation of digital technologies into the cardiovascular care pathway has enormous potential to lighten the load on the National Health Service (NHS), however, it is not possible to adopt this shift without embedding the perspectives of service users and clinicians. Methods and analysis A series of qualitative studies will be carried out with the aim of developing a stakeholder-led perspective on the implementation of digital technologies to improve holistic diagnosis of heart disease. This will be a decentralised study with all data collection being carried out online with a nationwide cohort. Four focus groups, each with 5–6 participants, will be carried out with people with lived experience of heart disease, and 10 one-to-one interviews will be carried out with clinicians with experience of diagnosing heart diseases. The data will be analysed using an inductive thematic analysis approach. Ethics and dissemination This study received ethical approval from the Sciences and Technology Cross Research Council at the University of Sussex (reference ER/FM409/1). Participants will be required to provide informed consent via a Qualtrics survey before being accepted into the online interview or focus group. The findings will be disseminated through conference presentations, peer-reviewed publications and to the study participants.

5 March 2025 in JMIR Cardio
Verified
Journal Article
Open access
KAKamilla Abdullayev
Kamilla Abdullayev
TCTimothy James Chico
Timothy James Chico
JCJiana Canson
Jiana Canson
MMMatthew Manktelow
Matthew Manktelow
OBOli Buckley
Oli Buckley
FMFaith Matcham
Faith Matcham
Background: Digital technologies are increasingly being implemented in health care to improve the quality and efficiency of care for patients. However, the rapid adoption of health technologies over the last 5 years has failed to adequately consider patient and clinician needs, which results in ineffective implementation. There is also a lack of consideration for the differences between patient and clinician needs, resulting in overgeneralized approaches to the implementation and use of digital health technologies. Objective: This study aimed to explore barriers and facilitators of the implementation of digital technologies in the diagnosis of heart disease for both patients and clinicians, and to provide recommendations to increase the acceptability of novel health technologies. Methods: We recruited 32 participants from across the United Kingdom, including 23 (72%) individuals with lived experience of heart disease and 9 (28%) clinicians involved in diagnosing heart disease. Participants with experience of living with heart disease took part in semistructured focused groups, while clinicians contributed to one-to-one semistructured interviews. Inductive thematic analysis using a phenomenological approach was conducted to analyze the resulting qualitative data and to identify themes. Results were discussed with a cardiovascular patient advisory group to enhance the rigor of our interpretation of the data. Results: Emerging themes were separated into facilitators and barriers and categorized into resource-, technology-, and user-related themes. Resource-related barriers and facilitators related to concerns around increased clinician workload, the high cost of digital technologies, and systemic limitations within health care systems such as outdated equipment and limited support. Technology-related barriers and facilitators included themes related to reliability, accuracy, safety parameters, data security, ease of use, and personalization, all of which can impact engagement and trust with digital technologies. Finally, the most prominent themes were the user-related barriers and facilitators, which encompassed user attitudes, individual-level variation in preferences and capabilities, and impact on quality of health care experiences. This theme captured a wide variety of perspectives among the sample and revealed how patient and clinician attitudes and personal experiences substantially impact engagement with digital health technologies across the cardiovascular care pathway. Conclusions: Our findings highlight the importance of considering both patient and clinician needs and preferences when investigating the barriers and facilitators to effective implementation of digital health technologies. Facilitators to technology adoption include the need for cost-effective, accurate, reliable, and easy-to-use systems as well as adequate setup support and personalization to meet individual needs. Positive user attitudes, perceived improvement in care quality, and increased involvement in the care process also enhance engagement. While both clinicians and patients acknowledge the potential benefits of digital technologies, effective implementation hinges on addressing these barriers and leveraging facilitators to ensure that the technologies are perceived as useful, safe, and supportive of health care outcomes. International Registered Report Identifier (IRRID): RR2-10.1136/bmjopen-2023-072952

13 September 2024 in JMIR Preprints
Verified
Preprint
Open access
KAKamilla Abdullayev
Kamilla Abdullayev
TCTimothy James Chico
Timothy James Chico
JCJiana Canson
Jiana Canson
MMMatthew Manktelow
Matthew Manktelow
OBOli Buckley
Oli Buckley
FMFaith Matcham
Faith Matcham
BACKGROUND Digital technologies are increasingly being implemented in health care to improve the quality and efficiency of care for patients. However, the rapid adoption of health technologies over the last 5 years has failed to adequately consider patient and clinician needs, which results in ineffective implementation. There is also a lack of consideration for the differences between patient and clinician needs, resulting in overgeneralized approaches to the implementation and use of digital health technologies. OBJECTIVE This study aimed to explore barriers and facilitators of the implementation of digital technologies in the diagnosis of heart disease for both patients and clinicians, and to provide recommendations to increase the acceptability of novel health technologies. METHODS We recruited 32 participants from across the United Kingdom, including 23 (72%) individuals with lived experience of heart disease and 9 (28%) clinicians involved in diagnosing heart disease. Participants with experience of living with heart disease took part in semistructured focused groups, while clinicians contributed to one-to-one semistructured interviews. Inductive thematic analysis using a phenomenological approach was conducted to analyze the resulting qualitative data and to identify themes. Results were discussed with a cardiovascular patient advisory group to enhance the rigor of our interpretation of the data. RESULTS Emerging themes were separated into facilitators and barriers and categorized into resource-, technology-, and user-related themes. Resource-related barriers and facilitators related to concerns around increased clinician workload, the high cost of digital technologies, and systemic limitations within health care systems such as outdated equipment and limited support. Technology-related barriers and facilitators included themes related to reliability, accuracy, safety parameters, data security, ease of use, and personalization, all of which can impact engagement and trust with digital technologies. Finally, the most prominent themes were the user-related barriers and facilitators, which encompassed user attitudes, individual-level variation in preferences and capabilities, and impact on quality of health care experiences. This theme captured a wide variety of perspectives among the sample and revealed how patient and clinician attitudes and personal experiences substantially impact engagement with digital health technologies across the cardiovascular care pathway. CONCLUSIONS Our findings highlight the importance of considering both patient and clinician needs and preferences when investigating the barriers and facilitators to effective implementation of digital health technologies. Facilitators to technology adoption include the need for cost-effective, accurate, reliable, and easy-to-use systems as well as adequate setup support and personalization to meet individual needs. Positive user attitudes, perceived improvement in care quality, and increased involvement in the care process also enhance engagement. While both clinicians and patients acknowledge the potential benefits of digital technologies, effective implementation hinges on addressing these barriers and leveraging facilitators to ensure that the technologies are perceived as useful, safe, and supportive of health care outcomes. INTERNATIONAL REGISTERED REPORT RR2-10.1136/bmjopen-2023-072952

29 September 2023 in medRxiv
Verified
Preprint
Open access
PDF file
KAKamilla Abdullayev
Kamilla Abdullayev
OGOlivia Gorvett
Olivia Gorvett
ASAnna Sochiera
Anna Sochiera
LLLynn Laidlaw
Lynn Laidlaw
TCTimothy James Chico
Timothy James Chico
VDVanessa Diaz
Vanessa Diaz
Objective: The aim of this study is to understand stakeholder experiences of cardiovascular disease (CVD) diagnosis to support the development of technological solutions that meet current needs. Specifically, we aimed to identify challenges faced by stakeholders in the process of diagnosis of CVD; to identify discrepancies between patient and clinician experiences of CVD diagnosis, and to make recommendations for the requirements of future health technology solutions intended to improve CVD diagnosis. Design: The qualitative data was obtained using semi-structured focus groups and 1-1 interviews. Participants: UK-based individuals (N = 32) with lived experience of diagnosis of CVD (n = 23) and clinicians with experience in diagnosing CVD (n = 9). Results: Thematic analysis of focus groups and interview transcripts produced four key themes related to challenges contributing to delayed or inaccurate diagnosis of CVD: Symptom Interpretation, Patient Characteristics, Patient-Clinician Interactions, and Systemic Challenges. Sub-themes from each theme are discussed in depth. Conclusions: Challenges related to time and communication were greatest for both stakeholder groups, however there were differences in other areas, for example patient experiences highlighted difficulties with the psychological aspects of diagnosis and interpreting ambiguous symptoms, while clinicians emphasised the role of individual patient differences and the lack of rapport in contributing to delays or inaccurate diagnosis. Key takeaways from this qualitative study were summarised into a table of considerations to highlight key areas that require prioritisation for future research aiming to improve the efficiency and accuracy of CVD diagnosis using digital technologies.

15 February 2023 in medRxiv
Verified
Preprint
Open access
PDF file
KAK Abdullayev
K Abdullayev
TCTja Chico
Tja Chico
MMM Manktelow
M Manktelow
OBO Buckley
O Buckley
JCJ Condell
J Condell
FMFaith Matcham
Faith Matcham
Introduction Cardiovascular diseases are highly prevalent amongst the UK population, and the quality of care is being reduced due to accessibility and resource issues. Increased implementation of digital technologies into the cardiovascular care pathway has enormous potential to lighten the load on the NHS, however, it is not possible to adopt this shift without embedding the perspectives of service users and clinicians. Methods and Analysis A series of qualitative studies will be carried out with the aim of developing a stakeholder-led perspective on the implementation of digital technologies to improve holistic diagnosis of heart disease. Focus groups will be carried out with 20 people with lived experience of heart disease, and interviews will be carried out with 10 clinicians with experience of diagnosing heart diseases. The data will be analysed using an inductive thematic analysis approach. Ethics and Dissemination This study received ethical approval from the Sciences and Technology Cross Research Council at the University of Sussex. The findings will be disseminated through conference presentations, peer-reviewed publications and to the study participants. Strengths and Limitations The study materials have been informed by patient advisory boards, meaning they are sensitive to the experiences of the participants and the clinicians that will be recruited. The study will allow an in-depth understanding of the attitudes and experience of people with lived experience of heart disease and clinicians with experience of diagnosing heart disease. The use of an online research platform for participant recruitment will disadvantage those less comfortable using online resources. This may include those living in deprived areas without access to high quality technologies (which disproportionately excludes ethnic minority groups) and clinical populations with comorbidities that prevent the use of certain technologies, such as visual, auditory, physical, or learning impairments. The use of thematic analysis will not be free from the influence of the researcher’s personal experience and knowledge